Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC)
A new approach to diagnosing kidney cancer, called the Cambridge [...]
Cancer waiting times: latest update
NHS cancer services have faced growing pressure in recent years, [...]
Quit smoking this New Year for a healthier you!
Smoking is one of the risk factors for the development [...]
89Zr-girentuximab PET/CT effect on management of patients with kidney masses
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
Five year follow-up of belzutifan for VHL disease
VHL disease is a hereditary disease that affects many organs of [...]
Five-year follow-up results of adjuvant pembrolizumab for kidney cancer
Surgery (partial or radical nephrectomy) is the standard of care for [...]
Patient guide on immune-related side effects and their management
The European Society for Medical Oncology (ESMO) has published a [...]
UK-US trade deal for medicines
On 1st December 2025, the government announced a new UK-US [...]
Neoadjuvant therapy helps partial nephrectomy for kidney cancer
Neoadjuvant therapy is treatment that is given before surgery to help [...]
Stopping treatment with immunotherapy after immune-related side effects seems to have favourable outcomes
A recent study wanted to find out what happens to [...]
